The P2 receptor antagonist PPADS supports recovery from experimental stroke in vivo

PLoS ONE

Volumn 6, Issue 5, 2011, Pages

  Lämmer, Alexandra B ^a,b   Beck, Alexander ^a   Grummich, Benjamin ^b   Förschler, Annette ^b   Krügel, Thomas ^b   Kahn, Thomas ^b   Schneider, Dietmar ^b   Illes, Peter ^b   Franke, Heike ^b   Krügel, Ute ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PURINERGIC P2 RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; DRUG DERIVATIVE; PURINERGIC P2 RECEPTOR ANTAGONIST; PYRIDOXAL 5 PHOSPHATE; PYRIDOXAL PHOSPHATE-6-AZOPHENYL-2',4'-DISULFONIC ACID;

ALPHA RHYTHM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN INFARCTION SIZE; BRAIN ISCHEMIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DELTA RHYTHM; IN VIVO STUDY; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; MOTOR DYSFUNCTION; NERVE CELL; NERVOUS SYSTEM ELECTROPHYSIOLOGY; NONHUMAN; RAT; RECEPTOR BLOCKING; SPONTANEOUSLY HYPERTENSIVE RAT; TREATMENT RESPONSE; ANIMAL; CELL DEATH; CEREBRAL ARTERY DISEASE; CONVALESCENCE; DRUG EFFECT; ELECTROENCEPHALOGRAPHY; IMMUNOHISTOCHEMISTRY; MOTOR ACTIVITY; NICK END LABELING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; ROTAROD TEST; STROKE; TIME;

RATTUS;

ANIMALS; CELL DEATH; ELECTROENCEPHALOGRAPHY; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INFARCTION, MIDDLE CEREBRAL ARTERY; MAGNETIC RESONANCE IMAGING; MALE; MOTOR ACTIVITY; PURINERGIC P2 RECEPTOR ANTAGONISTS; PYRIDOXAL PHOSPHATE; RATS; RATS, INBRED SHR; RECOVERY OF FUNCTION; ROTAROD PERFORMANCE TEST; STROKE; TIME FACTORS;

EID: 79956118557     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019983     Document Type: Article

References (68)

1. Thomalla G, Schwark C, Sobesky J, Bluhmki E, Fiebach JB, et al. (2006) Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 37: 852-858.
2. Ginsberg MD, (2009) Current status of neuroprotection for cerebral ischemia: synoptic overview. Stroke 40: S111-S114.
3. Hossmann KA, (2009) Pathophysiological basis of translational stroke research. Folia Neuropathol 47: 213-227.
4. Hossmann KA, (2006) Pathophysiology and therapy of experimental stroke. Cell Mol Neurobiol 26: 1057-1083.
5. Ralevic V, Burnstock G, (1998) Receptors for purines and pyrimidines. Pharmacol Rev 50: 413-492.
6. Fischer W, Krügel U, (2007) P2Y receptors: Focus on structural, pharmacological and functional aspects in the brain. Curr Med Chem 14: 2429-2455.
7. Abbracchio MP, Burnstock G, Verkhratsky A, Zimmermann H, (2009) Purinergic signalling in the nervous system: an overview. Trends Neurosci 32: 19-29.
8. Braun N, Zhu Y, Krieglstein J, Culmsee C, Zimmermann H, (1998) Upregulation of the enzyme chain hydrolyzing extracellular ATP after transient forebrain ischemia in the rat. J Neurosci 18: 4891-4900.
9. Juranyi Z, Sperlagh B, Vizi ES, (1999) Involvement of P2 purinoceptors and the nitric oxide pathway in [3H]purine outflow evoked by short-term hypoxia and hypoglycemia in rat hippocampal slices. Brain Res 823: 183-190.
10. Melani A, Turchi D, Vannucchi MG, Cipriani S, Gianfriddo M, et al. (2005) ATP extracellular concentrations are increased in the rat striatum during in vivo ischemia. Neurochem Int 47: 442-448.
11. Franke H, Grummich B, Härtig W, Grosche J, Regenthal R, et al. (2006) Changes in purinergic signaling after cerebral injury - involvement of glutamatergic mechanisms? Int J Dev Neurosci 24: 123-132.
12. Burnstock G, Fredholm BB, Verkhratsky A, (2011) Adenosine and ATP Receptors in the Brain. Curr Top Med Chem (in press).
13. Szydlowska K, Tymianski M, (2010) Calcium, ischemia and excitotoxicity. Cell Calcium 47: 122-129.
14. Zhang Y, Deng P, Li Y, Xu ZC, (2006) Enhancement of excitatory synaptic transmission in spiny neurons after transient forebrain ischemia. J Neurophysiol 95: 1537-1544.
15. Neary JT, Kang Y, Willoughby KA, Ellis EF, (2003) Activation of Extracellular Signal-Regulated Kinase by Stretch-Induced Injury in Astrocytes Involves Extracellular ATP and P2 Purinergic Receptors. J Neurosci 23: 2348-2356.
16. Surprenant A, Rassendren F, Kawashima E, North RA, Buell G, (1996) The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science 272: 735-738.
17. Le Feuvre RA, Brough D, Touzani O, Rothwell NJ, (2003) Role of P2X7 receptors in ischemic and excitotoxic brain injury in vivo. J Cereb Blood Flow Metab 23: 381-384.
18. Nicke A, Kuan YH, Masin M, Rettinger J, Marquez-Klaka B, et al. (2009) A functional P2X7 splice variant with an alternative transmembrane domain 1 escapes gene inactivation in P2X7 knock-out mice. J Biol Chem 284: 25813-25822.
19. Verhoef PA, Estacion M, Schilling W, Dubyak GR, (2003) P2X7 receptor-dependent blebbing and the activation of Rho-effector kinases, caspases, and IL-1 beta release. J Immunol 170: 5728-5738.
20. Ferrari D, Chiozzi P, Falzoni S, Dal SM, Melchiorri L, et al. (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159: 1451-1458.
21. Suzuki T, Hide I, Ido K, Kohsaka S, Inoue K, et al. (2004) Production and release of neuroprotective tumor necrosis factor by P2X7 receptor-activated microglia. J Neurosci 24: 1-7.
22. Krügel U, Schraft T, Regenthal R, Illes P, Kittner H, (2004) Purinergic modulation of extracellular glutamate levels in the nucleus accumbens in vivo. Int J Dev Neurosci 22: 565-570.
23. Franke H, Sauer C, Rudolph C, Krügel U, Hengstler JG, et al. (2009) P2 receptor-mediated stimulation of the PI3-K/Akt-pathway in vivo. Glia 57: 1031-1045.
24. Ryu JK, Kim J, Choi SH, Oh YJ, Lee YB, et al. (2002) ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport 13: 1611-1615.
25. Wang X, Arcuino G, Takano T, Lin J, Peng WG, et al. (2004) P2X7 receptor inhibition improves recovery after spinal cord injury. Nat Med 10: 821-827.
26. Krügel U, Kittner H, Franke H, Illes P, (2001) Accelerated functional recovery after neuronal injury by P2 receptor blockade. Eur J Pharmacol 420: 3-4.
27. Kharlamov A, Jones SC, Kim DK, (2002) Suramin reduces infarct volume in a model of focal brain ischemia in rats. Exp Brain Res 147: 353-359.
28. Lämmer A, Günther A, Beck A, Krügel U, Kittner H, et al. (2006) Neuroprotective effects of the P2 receptor antagonist PPADS on focal cerebral ischaemia-induced injury in rats. Eur J Neurosci 23: 2824-2828.
29. Marin R, Williams A, Hale S, Burge B, Mense M, et al. (2003) The effect of voluntary exercise exposure on histological and neurobehavioral outcomes after ischemic brain injury in the rat. Physiol Behav 80: 167-175.
30. Murphy TH, Corbett D, (2009) Plasticity during stroke recovery: from synapse to behaviour. Nat Rev Neurosci 10: 861-872.
31. McCabe C, Gallagher L, Gsell W, Graham D, Dominiczak AF, et al. (2009) Differences in the evolution of the ischemic penumbra in stroke-prone spontaneously hypertensive and Wistar-Kyoto rats. Stroke 40: 3864-3868.
32. Dijkhuizen RM, Nicolay K, (2003) Magnetic resonance imaging in experimental models of brain disorders. J Cereb Blood Flow Metab 23: 1383-1402.
33. Paxinos P, Watson C, (1986) The rat brain in stereotaxic coordinates New York Academic Press.
34. Krügel U, Kittner H, Franke H, Illes P, (2003) Purinergic modulation of neuronal activity in the mesolimbic dopaminergic system in vivo. Synapse 47: 134-142.
35. Boltze J, Kowalski I, Förschler A, Schmidt U, Wagner D, et al. (2006) The stairway: a novel behavioral test detecting sensomotoric stroke deficits in rats. Artif Organs 30: 756-763.
36. Franke H, Günther A, Grosche J, Schmidt R, Rossner S, et al. (2004) P2X7 receptor expression after ischemia in the cerebral cortex of rats. J Neuropathol Exp Neurol 63: 686-699.
37. Brint S, Jacewicz M, Kiessling M, Tanabe J, Pulsinelli W, (1988) Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab 8: 474-485.
38. Barone FC, Price WJ, White RF, Willette RN, Feuerstein GZ, (1992) Genetic hypertension and increased susceptibility to cerebral ischemia. Neurosci Biobehav Rev 16: 219-233.
39. Taoufik E, Probert L, (2008) Ischemic neuronal damage. Curr Pharm Des 14: 3565-3573.
40. Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP, (2009) Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 32: 79-87.
41. Nuwer MR, Jordan SE, Ahn SS, (1987) Evaluation of stroke using EEG frequency analysis and topographic mapping. Neurology 37: 1153-1159.
42. Faught E, (1993) Current role of electroencephalography in cerebral ischemia. Stroke 24: 609-613.
43. Finnigan SP, Walsh M, Rose SE, Chalk JB, (2007) Quantitative EEG indices of sub-acute ischaemic stroke correlate with clinical outcomes. Clin Neurophysiol 118: 2525-2532.
44. Moyanova S, Kortenska L, Kirov R, Iliev I, (1998) Quantitative electroencephalographic changes due to middle cerebral artery occlusion by endothelin 1 in conscious rats. Arch Physiol Biochem 106: 384-391.
45. Lu XC, Williams AJ, Tortella FC, (2001) Quantitative electroencephalography spectral analysis and topographic mapping in a rat model of middle cerebral artery occlusion. Neuropathol Appl Neurobiol 27: 481-495.
46. Finnigan SP, Rose SE, Chalk JB, (2006) Rapid EEG changes indicate reperfusion after tissue plasminogen activator injection in acute ischaemic stroke. Clin Neurophysiol 117: 2338-2339.
47. Feeney DM, Gonzalez A, Law WA, (1982) Amphetamine, haloperidol, and experience interact to affect rate of recovery after motor cortex injury. Science 217: 855-857.
48. Hamm RJ, Pike BR, O'Dell DM, Lyeth BG, Jenkins LW, (1994) The rotarod test: an evaluation of its effectiveness in assessing motor deficits following traumatic brain injury. J Neurotrauma 11: 187-196.
49. Zhang L, Chen J, Li Y, Zhang ZG, Chopp M, (2000) Quantitative measurement of motor and somatosensory impairments after mild (30 min) and severe (2 h) transient middle cerebral artery occlusion in rats. J Neurol Sci 174: 141-146.
50. Beaumont E, Houle JD, Peterson CA, Gardiner PF, (2004) Passive exercise and fetal spinal cord transplant both help to restore motoneuronal properties after spinal cord transection in rats. Muscle Nerve 29: 234-242.
51. Brecht S, Gelderblom M, Srinivasan A, Mielke K, Dityateva G, et al. (2001) Caspase-3 activation and DNA fragmentation in primary hippocampal neurons following glutamate excitotoxicity. Brain Res Mol Brain Res 94: 25-34.
52. Noto T, Ishiye M, Furuich Y, Keida Y, Katsuta K, et al. (2004) Neuroprotective effect of tacrolimus (FK506) on ischemic brain damage following permanent focal cerebral ischemia in the rat. Brain Res Mo. Brain Res 128: 30-38.
53. Sims NR, Muyderman H, (2010) Mitochondria, oxidative metabolism and cell death in stroke. Biochim Biophys Acta 1802: 80-91.
54. Candelario-Jalil E, (2009) Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr Opin Investig Drugs 10: 644-654.
55. Jacobson KA, Kim YC, Wildman SS, Mohanram A, Harden TK, et al. (1998) A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. J Med Chem 41: 2201-2206.
56. Lambrecht G, (2000) Agonists and antagonists acting at P2X receptors: selectivity profiles and functional implications. Naunyn Schmiedebergs Arch Pharmacol 362: 340-350.
57. von Kügelgen I, (2006) Pharmacological profiles of cloned mammalian P2Y-receptor subtypes. Pharmacol Ther 110: 415-432.
58. Duan S, Neary JT, (2006) P2X(7) receptors: properties and relevance to CNS function. Glia 54: 738-746.
59. Le Feuvre R, Brough D, Rothwell N, (2002) Extracellular ATP and P2X7 receptors in neurodegeneration. Eur J Pharmacol 447: 261-269.
60. Melani A, Amadio S, Gianfriddo M, Vannucchi MG, Volonte C, et al. (2006) P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J Cereb Blood Flow Metab 26: 974-982.
61. Friedle SA, Curet MA, Watters JJ, (2010) Recent patents on novel P2X(7) receptor antagonists and their potential for reducing central nervous system inflammation. Recent Pat CNS Drug Discov 5: 35-45.
62. Tuttolomondo A, Di Sciacca R, Di Raimondo D, Renda C, Pinto A, et al. (2009) Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem 9: 1240-1260.
63. Franke H, Schepper C, Illes P, Krügel U, (2007) Involvement of P2X and P2Y receptors in microglial activation in vivo. Purinergic Signal 3: 435-445.
64. Choi HB, Ryu JK, Kim SU, McLarnon JG, (2007) Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. J Neurosci 27: 4957-4968.
65. Hide I, Tanaka M, Inoue A, Nakajima K, Kohsaka S, et al. (2000) Extracellular ATP triggers tumor necrosis factor-alpha release from rat microglia. J Neurochem 75: 965-972.
66. Cavaliere F, Florenzano F, Amadio S, Fusco FR, Viscomi MT, et al. (2003) Up-regulation of P2X2, P2X4 receptor and ischemic cell death: prevention by P2 antagonists. Neuroscience 120: 85-98.
67. Cavaliere F, Amadio S, Angelini DF, Sancesario G, Bernardi G, et al. (2004) Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor. Exp Cell Res 300: 149-158.
68. Franke H, Krügel U, Grosche J, Heine C, Härtig W, et al. (2004) P2Y receptor expression on astrocytes in the nucleus accumbens of rats. Neuroscience 127: 431-441.